Decoding the latent molecular interactions between aspartame and hepatocellular carcinoma: A multi-omics and machine learning integration
By: Zhou An, Xianhua Wang and Yuyun Jia
References
- Seesen M, Chang K, Parnham JC, Laverty AA, Millett C, Rauber F, Levy RB, White M, Gregg EW, Vamos EP. Association of low-calorie sweetened product consumption and intakes of free sugar and ultra-processed foods in UK children: a national study from 2008 to 2019. Eur J Nutr. 2025; 64: 230.
- Pat Y, Yazici D, Zeyneloglu C, Babayev H, Ardicli S, Garci-Sanchez A, Bu X, Heider A, Viscardi OG, Chang L, et al. Cellular stress, inflammation and barrier damage in gut epithelial cells caused by aspartame. Allergy. 2026;81(3): 884–901.
- Doueihy NE, Ghaleb J, Kfoury K, Khouzami KK, Nassif N, Attieh P, Ghadieh HE, Azar S, Kanaan A, Harb F. Aspartame and human health: A mini-review of carcinogenic and systemic effects. J Xenobiot. 2025;15(4): 114.
- Sun W, Huo S, Li S, Yang D, Wei C, Zheng J, Cai S. Evaluating the role of glutathione reductase in aspartame-induced liver hepatocellular carcinoma: A molecular network and prognostic approach. Toxicol Lett. 2025; 413: 111748.
- Guo J, Liang R, Chung A, Li Z, Li B, Chen E, Li L, Wang J, Hsieh MH, Fang IX, et al. The origin of hepatocellular carcinoma depends on metabolic zonation. Science. 2026;391(6784): eadv7129.
- Kim SY, Hwangbo H, Kim GY, Choi YH. Inactivation of the reactive oxygen species-dependent PI3K/Akt/Mtor signaling pathway by phloroglucinol contributes to cytotoxicity in Hep3B human hepatocellular carcinoma cells. Cell Physiol Biochem. 2025;59: 389–403.
- Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6): 882–883.
- Liu Y, Shao J, Zhang J, Sang M, Xu Q, Mao L. Development and experimental validation of machine learning-based disulfidptosis-related ferroptosis biomarkers in inflammatory bowel disease. Genes (Basel). 2025;16(5): 496.
- Tang J, Yuan L, Han YL. Metabolic-immune crosstalk in myocardial infarction: RLF and SMCHD1 identified as causal therapeutic targets via integrated lactylation-MR analysis. Front Cell Dev Biol 2025; 13: 1653551.
- Jin M, Ni D, Cai J, Yang J. Identification and validation of immunity- and disulfidptosis-related genes signature for predicting prognosis in ovarian cancer. Heliyon. 2024;10(12): e32273.
- Yang J, Luo M, Wang H, Huang J. Phthalates unleashed: decoding ovarian carcinogenesis through multi-omics networks, single-cell insights, and molecular docking. J Ovarian Res. 2025;18(1): 131.
- Li NR, Zeng YX, Gu YF, Xie P, Deng BY, Lu SF, Li WA, Liu Y. Aspartame increases the risk of liver cancer through CASP1 protein: A comprehensive network analysis insights. Ecotoxicol Environ Saf. 2025;294: 118089.
- Soffritti M. Understanding the link between aspartame and cancer. Expert Rev Anticancer Ther. 2024; 24: 793–802.
- U-pathi J, Yeh YC, Chen CW, Owaga EE, Hsieh RH. Relationship between aspartame-induced cerebral cortex injury and oxidative stress, inflammation, mitochondrial dysfunction, and apoptosis in sprague dawley rats. Antioxidants (Basel). 2023;13(1): 2.
- Goodman JE, Boon DN, Jack MM. Perspectives on recent reviews of aspartame cancer epidemiology. Glob Epidemiol. 2023;6: 100117.
- Griebsch LV, Theiss EL, Janitschke D, Erhardt VKJ, Erhardt T, Haas EC, Kuppler KN, Radermacher J, Walzer O, Lauer AA, et al. Aspartame and its metabolites cause oxidative stress and mitochondrial and lipid alterations in SH-SY5Y cells. Nutrients. 2023;15(6): 1467.
- Wei X, Zhu H, Yu H, Li T. Ginsenoside inhibits aerobic glycolysis in hepatocellular carcinoma through the hsa-miR-139-5p/AURKA axis. Cell Signal. 2025; 136: 112177.
- Lv C, Liu Y, Zhang H. The oncogenic role of AURKA in gastric cancer: Mechanisms, pathways, and clinical relevance. Carcinogenesis. 2025; Sep 9:bgaf054. 10.1093/carcin/bgaf054. Epub ahead of print. PMID: 40924158.
- Bai G, Wang L, Zhang L, Eli M. ZNF468/AURKA/PI3K/AKT Positive feedback loop promotes proliferation and metastasis of oesophageal squamous cell carcinoma. J Cell Mol Med. 2025;29(14): 70724.
- Sato M, Yamamoto Y, Moriwaki T, Fukuda K, Tsuchiya K. Combination of AURKA inhibitor and MEK inhibitor strongly enhances G1 arrest and induces synergistic antitumor effect on KRAS or BRAF mutant colon cancer cells. Biochem Biophys Rep. 2025; 43: 102073.
- Wu J, Luo H, Wang K, Yi B. Development and validation of a novel diagnostic nomogram model using serum oxidative stress markers and AURKA for prediction of nasopharyngeal carcinoma. Cancer Manag Res. 2023; 15: 1053–1062.
- Wang Y, Li Q, Ding Y, Luo C, Yang J, Wang N, Jiang N, Yao T, Wang G, Shi G, et al. Novel arf1 inhibitors drive cancer stem cell aging and potentiate anti-tumor immunity. Adv Sci (Weinh). 2024;11(39): 2404442.
- Li Q, Li F, Song X, Lu N, Jing X, Wen H, Ma P, Zhang H, Yao W, Wang X, et al. Pan-cancer analysis of ARFs family and ARF5 promoted the progression of hepatocellular carcinoma. Heliyon. 2024;10(7): e29099.
- Jiang YY, Wu S, Wu YW, Gao Y, Chong D, Sun C, Wei MY, Gu YC, Shao CL, Gu Y. New brefeldin A-cinnamic acid ester derivatives as potential antitumor agents: Design, synthesis and biological evaluation. Eur J Med Chem. 2022; 240: 114598.
- Zhan X, Zheng Y, Yang J, Chen Z. Mechanism of UHRF1 protein macromolecule regulating ferroptosis in liver cancer: inhibition of GSTZ1 expression through DNA methylation. Int J Biol Macromol. 2025;311(Pt 4): 144060.
- Li J, Wang Q, Yang Y, Lei C, Yang F, Liang L, Chen C, Xia J, Wang K, Tang N. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway. J Exp Clin Cancer Res. 2019;38(1): 438.
- Wang Q, Bin C, Xue Q, Gao Q, Huang A, Wang K, Tang N. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis. Cell Death Dis. 2021;12(5): 426.
- Li H, Chai X. RND3 inhibits endometriosis progression by regulating autophagy and oxidative stress through PLEKHG5. FASEB J. 2025;39(20): e71121.
- Ji L, Li X, Gao B. Comprehensive multi-omics data to construct hepatocellular carcinoma pathway subtypes and classification model. Comput Biol Chem. 2026;120(Pt 2): 108753.
- Xu L, Huang B, Zhou Y, Liao X, Chen T, He H. Multi-omics-based decoding of circulating biomarkers in amyotrophic lateral sclerosis and risks in environmental toxins. BMC Pharmacol Toxicol. 2025;26(1): 86.
- Kant S, Deepika, Roy S. Integrative multi-omics and artificial intelligence: A new paradigm for systems biology. OMICS. 2025;29(12): 576–587.
- Li G, Tian Y, Gao Z. The role of AURKA/miR-199b-3p in hepatocellular carcinoma cells. J Clin Lab Anal 2022, 36: e24758.
- Mitra T, Vardhana SA. Between ROS and a hard place: telomere damage as a driver of T cell exhaustion. Cancer Res. 2026; 86(1): 10–11.
DOI: https://doi.org/10.2478/ahem-2026-0007 | Journal eISSN: 1732-2693
Language: English
Page range: 68 - 80
Submitted on: Nov 25, 2025
Accepted on: Apr 17, 2026
Published on: Apr 18, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Related subjects:
© 2026 Zhou An, Xianhua Wang, Yuyun Jia, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.